Celltrion to Conduct Trial of Remsima as COVID-19 Therapeutics in UK
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
No Result
View All Result
FREE NEWSLETTER
PRODUCTS
Most Popular
5 Best Korean to English Translation Apps
Top South Korean Tech Products to Look Out for in 2021
Best Korean Dramas To Watch This 2021
5 All-Time Best Rom-Com K-Dramas to Watch
Top Nine Mobile MMORPG in South Korea for 2020
Top Eight Promising EdTech Startup Companies in South Korea
Coway Changes Name After Netmarble’s Aquisition
Top 8 South Korean Mobile MMORPG to Watch Out For in 2021
Top 10 Must-Have Korean Apps You Need When Visiting in Korea
KT Continues to Accelerate Its ‘Digico’ Transformation
Copyright © 2022 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |